Exagen is a biotechnology company engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention.
MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization.
Icosavax is a biotechnology company that develops virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on respiratory diseases.